Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

Abstract Background There are no specific generally accepted therapies for the coronavirus disease 2019 (COVID-19). The full spectrum of COVID-19 ranges from asymptomatic disease to mild respiratory tract illness to severe pneumonia, acute respiratory distress syndrome (ARDS), multisystem organ fail...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jesús Villar, José M. Añón, Carlos Ferrando, Gerardo Aguilar, Tomás Muñoz, José Ferreres, Alfonso Ambrós, César Aldecoa, Fernando Suárez-Sipmann, Kevin E. Thorpe, Peter Jüni, Arthur S. Slutsky, the DEXA-COVID19 Network
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-08-01
coleção:	Trials
Assuntos:	Acute respiratory distress syndrome Coronavirus disease 19 COVID-19 Dexamethasone Corticosteroids Lung protective ventilation
Acesso em linha:	http://link.springer.com/article/10.1186/s13063-020-04643-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!